The long and winding road to optimal HbA1c measurement
2013/01/11 by Randie R. Little, Curt L. Rohlfing · 26 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Comparability #Computer science #Diabetes Management and Research #Diabetes Treatment and Management #Diabetes mellitus #Intensive care medicine #Medicine #Metabolism, Diabetes, and Cancer #Standardization #Type 2 diabetes #United Kingdom Prospective Diabetes Study
paper · doi:10.1016/j.cca.2012.12.026
openalex publication_date 2013/01/11 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/25
Cited by
- Type 1 diabetes mellitus
- Treating type 1 diabetes: from strategies for insulin delivery to dual hormonal control. [europepmc]
- Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management. [europepmc]
- Aptamer- Based Label-Free Electrochemical Biosensor Array for the Detection of Total and Glycated Hemoglobin in Human Whole Blood. [europepmc]
- Modifications of hemoglobin and myoglobin by Maillard reaction products (MRPs). [europepmc]
- A degradation fragment of type X collagen is a real-time marker for bone growth velocity. [europepmc]
- Update on biomarkers of glycemic control. [europepmc]
- Evaluation of a human glycated hemoglobin test in canine diabetes mellitus. [europepmc]
- Association between eating behavior and poor glycemic control in Japanese adults. [europepmc]
- Relationships of Obesity-Related Indices and Metabolic Syndrome with Subclinical Atherosclerosis in Middle-Aged Untreated Japanese Workers. [europepmc]
- Increased Levels of Glycated Hemoglobin A1c and Iron Deficiency Anemia: A Review. [europepmc]
- Time in Specific Glucose Ranges, Glucose Management Indicator, and Glycemic Variability: Impact of Continuous Glucose Monitoring (CGM) System Model and Sensor on CGM Metrics. [europepmc]
- Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double blind, phase 3 study (PRESS XII study). [europepmc]
- Implementing a Diabetes Education Program to Reduce Health Disparities in South Texas: Application of the RE-AIM Framework for Planning and Evaluation. [europepmc]
- Effects of COVID-19 lockdown on type 2 diabetes, lifestyle and psychosocial health: A hospital-based cross-sectional survey from South India. [europepmc]
- Association of Improved Periconception Hemoglobin A1c With Pregnancy Outcomes in Women With Diabetes. [europepmc]
- Using Community Health Workers and a Smartphone Application to Improve Diabetes Control in Rural Guatemala. [europepmc]
- Racial differences in patient perception of interactions with providers are associated with health outcomes in type II diabetes. [europepmc]
- Latinos understanding the need for adherence in diabetes (LUNA-D): a randomized controlled trial of an integrated team-based care intervention among Latinos with diabetes. [europepmc]
- Effectiveness of an adapted diabetes nutrition education program on clinical status, dietary behaviors and behavior mediators in adults with type 2 diabetes: a randomized controlled trial. [europepmc]
- Digital Behavior Change Interventions for the Prevention and Management of Type 2 Diabetes: Systematic Market Analysis. [europepmc]
- Effects of an integrated mindfulness intervention for veterans with diabetes distress: a randomized controlled trial. [europepmc]
- Association Between Mobile Health App Engagement and Weight Loss and Glycemic Control in Adults With Type 2 Diabetes and Prediabetes (D'LITE Study): Prospective Cohort Study. [europepmc]
- Clinical outcomes of a large-scale, partnership-based regional food prescription program: results of a quasi-experimental study. [europepmc]
- Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c. [europepmc]
- The Need for Standardization of Continuous Glucose Monitoring Performance Evaluation: An Opinion by the International Federation of Clinical Chemistry and Laboratory Medicine Working Group on Continuous Glucose Monitoring. [europepmc]